Showing Results for
- Academic Journals (25)
Search Results
- 25
Academic Journals
- 25
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedBardet-Biedl syndrome (BBS) is a syndromic ciliopathy that has obesity as a cardinal feature. BBS is caused by mutations in BBS genes. BBS proteins control primary cilia function, and BBS mutations therefore lead to...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedThe excitability of interneurons requires [Na.sub.v]1.1, the a subunit of the voltage-gated sodium channel. [Na.sub.v]1.1 deficiency and mutations reduce interneuron excitability, a major pathological mechanism for...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedLoss-of-function mutations of SCN1A encoding the pore-forming a subunit of the [Na.sub.V]1.1 neuronal sodium channel cause a severe developmental epileptic encephalopathy, Dravet syndrome (DS). In this issue of the JCI,...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedX-linked adrenoleukodystrophy (ALD) is a progressive neurodegenerative disease caused by mutations in ABCD1, the peroxisomal very long-chain fatty acid (VLCFA) transporter. ABCD1 deficiency results in accumulation of...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedArtificial intelligence has been applied to histopathology for decades, but the recent increase in interest is attributable to well-publicized successes in the application of deep-learning techniques, such as...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedIn humans receiving intestinal transplantation (ITx), long-term multilineage blood chimerism often develops. Donor T cell macrochimerism (>4%) frequently occurs without graft-versus-host disease (GVHD) and is associated...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedTo define the contribution of [CD8.sup.+] T cell responses to control of SIV reactivation during and following antiretroviral therapy (ART), we determined the effect of long-term [CD8.sup.+] T cell depletion using a...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedBACKGROUND. The coronavirus disease 2019 (COVID-19) rapidly progressed to a global pandemic. Although some patients totally recover from COVID-19 pneumonia, the disease's long-term effects on the brain still need to be...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedAberrant lipid metabolism promotes the development of skeletal muscle insulin resistance, but the exact identity of lipid-mediated mechanisms relevant to human obesity remains unclear. A comprehensive lipidomic analysis...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedAdoptive transfer of Tregs has been shown to improve alloengraftment in animal models. However, it is technically challenging to expand Tregs ex vivo for the purpose of infusing large numbers of cells in the clinic. We...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedSickle cell disease (SCD) is a monogenic disorder characterized by recurrent episodes of severe bone pain, multi-organ failure, and early mortality. Although medical progress over the past several decades has improved...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedAlthough cancer cells are frequently faced with a nutrient- and oxygen-poor microenvironment, elevated hexosaminebiosynthesis pathway (HBP) activity and protein O-GlcNAcylation (a nutrient sensor) contribute to rapid...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-Reviewed
Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis.
Efferocytosis, the process through which apoptotic cells (ACs) are cleared through actin-mediated engulfment by macrophages, prevents secondary necrosis, suppresses inflammation, and promotes resolution. Impaired... -
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedBardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder caused by mutations in genes encoding components of the primary cilium and is characterized by hyperphagic obesity. To investigate the molecular basis of...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedMelanomas commonly undergo a phenotype switch, from a proliferative to an invasive state. Such tumor cell plasticity contributes to immunotherapy resistance; however, the mechanisms are not completely understood and thus...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedSmall ubiquitin-like modifier (SUMO) binding (termed SUMOylation) emerged as the inducer for the sorting of bioactive molecules into extracellular vesicles (EVs), triggering lymphangiogenesis and further driving tumor...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedImmune checkpoint blockade therapy has demonstrated promising clinical outcomes for multiple cancer types. However, the emergence of resistance as well as inadequate biomarkers for patient stratification have largely...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedBACKGROUND. Patients with [p16.sup.+] oropharyngeal squamous cell carcinoma (OPSCC) are potentially cured with definitive treatment. However, there are currently no reliable biomarkers of treatment failure for...
-
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-Reviewed
Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection.
BACKGROUND. Rejection is the primary barrier to broader implementation of vascularized composite allografts (VCAs), including face and limb transplants. The immunologic pathways activated in face transplant rejection... -
From:Journal of Clinical Investigation (Vol. 131, Issue 8) Peer-ReviewedDysregulated immune profiles have been described in symptomatic patients infected with SARS-CoV-2. Whether the reported immune alterations are specific to SARS-CoV-2 infection or also triggered by other acute illnesses...